ghk-cu dosage subcutaneous or topical Guide 2026: mg/Week, Chart & Protocol GHK-Cu Dosing: 1.7mg/Day Injectable (2026)
Description
LTP of synaptic transmission is blocked by a DOR antagonist, without affecting potentiation of the population spike (Krug et al., 2001)
In the p1107 vector, the BLRP tag was placed at the 5 end of the inserted TF
updated 2024
While the research community eagerly awaits direct clinical trials, the scientific rationale is incredibly strong
